Cholesterol inhibits assembly and oncogenic activation of the EphA2 receptor

Ryan J Schuck1, Alyssa E Ward1, Amita R Sahoo2

  • 1Department of Biochemistry & Cellular and Molecular Biology, University of Tennessee, Knoxville, TN, USA.

Communications Biology
|March 12, 2025
PubMed

Insights

Cholesterol inhibits the self-assembly and oncogenic signaling of the receptor tyrosine kinase EphA2, a key driver of cancer metastasis. Lowering cholesterol promotes EphA2 assembly, suggesting cholesterol acts as a safeguard against cancer progression.

Area of Science:

  • Molecular biology
  • Cell biology
  • Cancer research

Background:

  • Receptor tyrosine kinase EphA2 promotes cancer metastasis.
  • EphA2 exists as monomers, dimers, and oligomers, but the pro-metastatic state is unknown.
  • Understanding EphA2 self-assembly is crucial for targeting cancer malignancy.

Purpose of the Study:

  • To investigate the role of EphA2 self-assembly states in pro-metastatic signaling.
  • To develop a method for quantifying membrane protein self-assembly.
  • To elucidate the regulatory role of cholesterol in EphA2 activity.

Main Methods:

  • Development of SiMPull-POP, a single-molecule method for membrane protein self-assembly quantification.
  • Cholesterol manipulation in plasma membranes.
  • Phosphorylation studies in various cell lines.
  • Investigation of signaling pathways involving protein kinase A and beta-adrenergic receptors.

Main Results:

  • Reduced plasma membrane cholesterol significantly promotes EphA2 self-assembly, mimicking the effect of the EphA2 ligand.
  • Cholesterol inhibits EphA2 assembly and phosphorylation at serine residues, a marker of oncogenic signaling.
  • Cholesterol inhibits EphA2 activity via an in-trans mechanism involving protein kinase A and beta-adrenergic receptor signaling.

Conclusions:

  • Cholesterol acts as an inhibitor of EphA2 self-assembly and oncogenic signaling.
  • Low cholesterol levels enhance EphA2 assembly and promote pro-metastatic signaling.
  • Cholesterol functions as a protective mechanism against uncontrolled EphA2 activation and cancer progression.

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K